SCHEMBL21064584

SCHEMBL21064584

CC(C)Cc1ccc(S(=O)(=O)c2ccc(CC(C)C)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
EPHX1 P07099 1/20 0.50
LMNA P02545 3/20 0.49
KDM4E B2RXH2 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 1/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 1/20 0.49
CXCR1 P25024 4/20 0.47
CXCR2 P25025 4/20 0.47
PTGS1 P23219 3/20 0.47
PTGS2 P35354 3/20 0.47
CYP2C9 P11712 2/20 0.47
AKR1C3 P42330 2/20 0.47
ALB P02768 1/20 0.47
ESR1 P03372 1/20 0.47
ALOX5 P09917 1/20 0.47
RARB P10826 1/20 0.47
ADRB3 P13945 1/20 0.47
NFKB1 P19838 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10181468 0.92 HTR6 (0.55) ALDH1A1EPHX1LMNAKDM4ESMN1; SMN2
SCHEMBL103049 0.92 GAA (0.61) ALDH1A1EPHX1LMNAKDM4ESMN1; SMN2
SCHEMBL21064633 0.86 ALDH1A1 (0.49) ALDH1A1EPHX1LMNAKDM4ESMN1; SMN2
SCHEMBL2662553 0.84 ALDH1A1 (0.59) ALDH1A1LMNAKDM4ESMN1; SMN2MEN1
SCHEMBL21446843 0.83 HTT (0.61) ALDH1A1LMNAKDM4ESMN1; SMN2
SCHEMBL3092073 0.83 CA2 (0.61) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10180353 0.83 PSIP1 (0.59) ALDH1A1LMNAKDM4ESMN1; SMN2MEN1
SCHEMBL22623288 0.83 ALDH1A1 (0.58) ALDH1A1LMNAKDM4ESMN1; SMN2MEN1
SCHEMBL1546732 0.83 ALDH1A1 (0.58) ALDH1A1LMNAKDM4ESMN1; SMN2MEN1
SCHEMBL3193037 0.83 ALDH1A1 (0.44) ALDH1A1EPHX1LMNASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10312455-B2 Delayed fluorescence material for organic electroluminescence device LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-06-04 US disclosed
CN-104112870-A Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same MITSUBISHI CHEM CORP 2014-10-22 CN disclosed
CN-102484281-A Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same MITSUBISHI CHEM CORP 2012-05-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10312455-B2 Delayed fluorescence material for organic electroluminescence device SOD1, GPX1, LEF1 ALDH1A1 352/4885EPHX1 281/4885LMNA 2972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.